National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Nutrition in Cancer Care (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/22/2008
Common Herbs Used by People With Cancer and Possible Food/Drug Interactions

Herbal  Possible Food/Drug Interactions 
Black cohosh May further reduce lipids or blood pressure when combined with prescription medications; may increase antiproliferative effect obtained with tamoxifen.
Chamomile May increase bleeding when used with anticoagulants; may increase sedative effect of benzodiazepines.
Dong quai May increase effects of warfarin.
Echinacea May interfere with immunosuppressive therapy.
Garlic May increase bleeding time with aspirin, dipyridamole, and warfarin; may increase effects and adverse effects of hyperglycemic agents.
Ginkgo biloba May increase bleeding time with aspirin, dipyridamole, and warfarin; may increase blood pressure when used with thiazide diuretics.
Ginseng May adversely affect platelet adhesiveness/blood coagulation; may increase hypoglycemia with insulin; may interfere with antipsychotic drugs; may cause hypertension when used long-term with caffeine.
Kava kava May increase central nervous system depression when used with alcohol and sedatives; may cause hepatotoxicity.[12,13]
St. John's wort May cause serotonin syndrome when used with antidepressants and drugs using p450 microsomal enzyme for metabolism.[14]
Ma huang (ephedra) Increases toxicity with beta-blockers, monoamine oxidase inhibitors, caffeine, and St. John’s wort.
Yohimbe Decreases effect of antidepressants, antihypertensives, hyperglycemic agents, monoamine oxidase inhibitors, and St. John’s wort.

References

  1. Center for Food Safety and Applied Nutrition.: Consumer Advisory: Kava-Containing Dietary Supplements May Be Associated with Severe Liver Injury. Washington, DC: U.S. Food and Drug Administration, CFSAN, 2002. Available online. Last accessed August 13, 2008. 

  2. Taylor CL: Letter to Health Care Professionals: FDA Issues Consumer Advisory That Kava Products May Be Associated with Severe Liver Injury. Washington, DC: U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, 2002. Available online. Last accessed August 13, 2008. 

  3. Piscitelli SC, Burstein AH, Chaitt D, et al.: Indinavir concentrations and St John's wort. Lancet 355 (9203): 547-8, 2000.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov